134 related articles for article (PubMed ID: 2579083)
1. Grading of bone tumors by analysis of nuclear DNA content using flow cytometry.
Mankin HJ; Connor JF; Schiller AL; Perlmutter N; Alho A; McGuire M
J Bone Joint Surg Am; 1985 Mar; 67(3):404-13. PubMed ID: 2579083
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
3. Relationship between histologic grade and cytofluorometric cellular DNA and RNA content in primary bone tumors.
Takeshita H; Kusuzaki K; Kuzuhara A; Tsuji Y; Ashihara T; Gebhardt MC; Mankin HJ; Springfield DS; Hirasawa Y
Anticancer Res; 2001; 21(2B):1271-7. PubMed ID: 11396198
[TBL] [Abstract][Full Text] [Related]
4. The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.
Pinto AE; Fonseca I; Soares J
Cancer; 1999 Jan; 85(2):273-81. PubMed ID: 10023692
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric determination of DNA content in malignant and benign bone tumours.
Heliö H; Karaharju E; Nordling S
Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence.
Lee SE; Currin SM; Paulson DF; Walther PJ
J Urol; 1988 Oct; 140(4):769-74. PubMed ID: 3047437
[TBL] [Abstract][Full Text] [Related]
7. Proliferative characteristics and ploidy of human brain tumors by DNA flow cytometry.
Danova M; Riccardi A; Mazzini G; Ucci G; Montecucco CM; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
Basic Appl Histochem; 1986; 30(2):175-80. PubMed ID: 3741314
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
9. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA ploidy analysis of feline mammary tumors.
Minke JM; Cornelisse CJ; Stolwijk JA; Kuipers-Dijkshoorn NJ; Rutteman GR; Misdorp W
Cancer Res; 1990 Jul; 50(13):4003-7. PubMed ID: 2354449
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors.
Frankfurt OS; Slocum HK; Rustum YM; Arbuck SG; Pavelic ZP; Petrelli N; Huben RP; Pontes EJ; Greco WR
Cytometry; 1984 Jan; 5(1):71-80. PubMed ID: 6199167
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry of renal oncocytoma: common occurrence of deoxyribonucleic acid polyploidy and aneuploidy.
Rainwater LM; Farrow GM; Lieber MM
J Urol; 1986 Jun; 135(6):1167-71. PubMed ID: 2423707
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
14. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry.
Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP
Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834
[TBL] [Abstract][Full Text] [Related]
15. A flow cytometric study on giant cell tumor of bone.
Guo W; Ren X; Feng C
Chin Med J (Engl); 1996 Feb; 109(2):134-7. PubMed ID: 8758338
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
[TBL] [Abstract][Full Text] [Related]
17. Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study.
Ladanyi M; Traganos F; Huvos AG
Cancer; 1989 Oct; 64(7):1521-6. PubMed ID: 2776111
[TBL] [Abstract][Full Text] [Related]
18. An image cytometric DNA-analysis in breast neoplasms. Parameters of DNA-aneuploidy and their relationship with conventional prognostic factors.
Longin A; Fontanière B; Pinzani V; Catimel G; Souchier C; Clavel M; Chauvin F
Pathol Res Pract; 1992 Jun; 188(4-5):466-72. PubMed ID: 1409073
[TBL] [Abstract][Full Text] [Related]
19. The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours.
Alho A; Skjeldal S; Melvik JE; Pettersen EO; Larsen TE
Anticancer Res; 1993; 13(6B):2383-7. PubMed ID: 8135471
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions.
Spyratos F; Briffod M; Gentile A; Brunet M; Brault C; Desplaces A
Anal Quant Cytol Histol; 1987 Dec; 9(6):485-94. PubMed ID: 3435626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]